MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Medical Device_Diagnostics
Acenxion Biosystems, Inc.
Attachments
envelope-square
Parents
*Architects: Infectious Disease _ Bacteriology_Antibiotics
*Architects: Medical Device_Diagnostics
*Contractors & Awardees: NIAID
*MTEC: Members
Industry: Kansas
Children
2021: ACENXION BIOSYSTEMS AWARDED $3 MILLION NIAID GRANT
Acenxion Biosystems (ACXBIO) is a privately funded company developing automated systems for bacteria detection in blood cultures and phenotypic antimicrobial susceptibility testing (AST).
Founded 2020
Kansas City, Kansas
Roy Swiger CEO, Acenxion (2022)
Seamlessly fitting into current clinical workflows, Acenxion’s scalable AST system reduces the time required for phenotypic testing to just 4-6 hours allowing clinicians rapid use of a precise, targeted treatment.